Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Lightmatter in the transaction. Lightmatter, a leader in photonic supercomputing, announced raising $400 million in Series D financing...
You must be a Standard 1 Year member to access this content.
Davis Polk advised GSK plc on the deal while Gunderson Dettmer represented Affinivax. GSK plc announced its acquisition of Affinivax, Inc. for a $2.1 billion upfront...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer advised Remix Therapeutics on the deal. Remix Therapeutics, a Massachusetts-based biotech company, announced its $70 million Series B financing which included participation from Surveyor, Foresite...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Lyndra Therapeutics on the deal. Lyndra Therapeutics, a developer of orally administered steady-state release pills, announced its $60.5...
You must be a Standard 1 Year member to access this content.
